-
1.
公开(公告)号:US20240115609A1
公开(公告)日:2024-04-11
申请号:US18319677
申请日:2023-05-18
Applicant: IMMATICS US, INC.
Inventor: Monique DAO , Steffen WALTER , Melinda MATA , Aleksandra NORWICKA , Yannick BULLIARD , Sarah MISSELL , Sabrina KUTTRUFF-COQUI , Norbert HILF
IPC: A61K35/17 , A61K31/663 , A61K31/675 , A61K38/20 , C07K14/54 , C07K14/55 , C12N5/00 , C12N5/0783 , C12N15/62 , C12N15/85
CPC classification number: A61K35/17 , A61K31/663 , A61K31/675 , A61K38/2013 , C07K14/5443 , C07K14/55 , C12N5/0018 , C12N5/0636 , C12N5/0638 , C12N15/62 , C12N15/8509 , A61K2035/122 , C12N2501/155 , C12N2501/2302 , C12N2501/2315 , C12N2501/515 , C12N2501/998 , C12N2740/10043
Abstract: The present disclosure relates to expansion and activation of T cells. In an aspect, the present disclosure relates to expansion and activation of γδ T cells that may be used for transgene expression. In another aspect, the disclosure relates to expansion and activation of γδ T cells while depleting α- and/or β-TCR positive cells. T cell populations comprising expanded γδ T cell and depleted or reduced α- and/or β-TCR positive cells are also provided for by the instant disclosure. The disclosure further provides for methods of using the disclosed T cell populations.
-
公开(公告)号:US20250002855A1
公开(公告)日:2025-01-02
申请号:US18886331
申请日:2024-09-16
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Mamta KALRA , Ali MOHAMED , Steffen WALTER , Yannick BULLIARD
IPC: C12N5/0783 , A61K39/00 , C07K14/725
Abstract: An in vitro method of expanding γδ T cells includes isolating γδ T cells from a blood sample of a human subject, activating the isolated γδ T cells in the presence of an aminobisphosphonate and/or a feeder cell and at least one cytokine, expanding the activated γδ T cells, and optionally restimulating the expanded γδ T cells.
-
公开(公告)号:US20210285011A1
公开(公告)日:2021-09-16
申请号:US17197927
申请日:2021-03-10
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Mamta KALRA , Yannick BULLIARD , Steffen WALTER , Ali MOHAMED
IPC: C12N15/86 , C12N15/10 , C07K14/725 , C12N15/113
Abstract: The present invention provides a mutated woodchuck post-transcriptional regulatory element (WPRE). In particular, the present invention relates to a mutated WPRE sequence that can efficiently express nucleotides of interest in a retroviral vector system. The present invention also relates to methods of delivering and expressing nucleotides of interest to a target cell.
-
公开(公告)号:US20240150790A1
公开(公告)日:2024-05-09
申请号:US18501269
申请日:2023-11-03
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Mamta KALRA , Yannick BULLIARD , Steffen WALTER , Ali MOHAMED
IPC: C12N15/86 , C07K14/725 , C12N15/10 , C12N15/113
CPC classification number: C12N15/86 , C07K14/7051 , C12N15/102 , C12N15/113 , C12N2830/48
Abstract: The present invention provides a mutated woodchuck post-transcriptional regulatory element (WPRE). In particular, the present invention relates to a mutated WPRE sequence that can efficiently express nucleotides of interest in a retroviral vector system. The present invention also relates to methods of delivering and expressing nucleotides of interest to a target cell.
-
公开(公告)号:US20220280564A1
公开(公告)日:2022-09-08
申请号:US17281095
申请日:2021-02-23
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Mamta KALRA , Ali MOHAMED , Steffen WALTER , Yannick BULLIARD
IPC: A61K35/17 , C07K14/725 , C12N5/0783
Abstract: An in vitro method of expanding γδ T cells includes isolating γδ T cells from a blood sample of a human subject, activating the isolated γδ T cells in the presence of an aminobisphosphonate and/or a feeder cell and at least one cytokine, expanding the activated γδ T cells, and optionally restimulating the expanded γδ T cells.
-
公开(公告)号:US20250075230A1
公开(公告)日:2025-03-06
申请号:US18824203
申请日:2024-09-04
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Mamta KALRA , Yannick BULLIARD , Steffen WALTER , Ali MOHAMED
IPC: C12N15/86 , A61K39/00 , C07K14/725 , C12N5/0783 , C12N15/10 , C12N15/113
Abstract: The present invention provides a mutated woodchuck post-transcriptional regulatory element (WPRE). In particular, the present invention relates to a mutated WPRE sequence that can efficiently express nucleotides of interest in a retroviral vector system. The present invention also relates to methods of delivering and expressing nucleotides of interest to a target cell.
-
公开(公告)号:US20250051418A1
公开(公告)日:2025-02-13
申请号:US18590008
申请日:2024-02-28
Applicant: Immatics US, Inc.
Inventor: Melinda MATA , Yannick BULLIARD , Mamta KALRA
IPC: C07K14/705 , A61K39/00 , C07K14/725 , C12N5/078 , C12N5/0783 , C12N15/64 , C12N15/86
Abstract: A vector containing a first nucleotide sequence S1 encoding a protein Z1, a second nucleotide sequence S2 encoding a protein Z2, a third nucleotide sequence S3 encoding a protein Y1, and a fourth nucleotide sequence S4 encoding a protein Y2, in which Z1 and Z2 form a first dimer and Y1 and Y2 form a second dimer, in which the first dimer Z1Z2 is different from the second dimer Y1Y2.
-
-
-
-
-
-